Combining immunotherapy with radiation for the treatment of glioblastoma
Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in...
Gespeichert in:
Veröffentlicht in: | Journal of neuro-oncology 2015-07, Vol.123 (3), p.459-464 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 464 |
---|---|
container_issue | 3 |
container_start_page | 459 |
container_title | Journal of neuro-oncology |
container_volume | 123 |
creator | Chow, Kevin K. H. Hara, Wendy Lim, Michael Li, Gordon |
description | Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in GBM have thus far shown modest benefit. Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence that radiation can enhance anti-tumor immunity. Here we review this evidence and discuss considerations for combined therapy. |
doi_str_mv | 10.1007/s11060-015-1762-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1709189807</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1695759969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-412162751374f155d8b1884fe91d3d95031297d7bf422c486be6b2e449f3b593</originalsourceid><addsrcrecordid>eNqFkU1rGzEQQEVJaBy3P6CXspBLL9to9DWrYzFJXTD04kNuQuvV2jK7K1fSEvLvs46dUAqhJx3mzRvEI-QL0O9AKd4mAKpoSUGWgIqV-gOZgUReIkd-QWYUFJZSi4crcp3SnlIqkMNHcsVkhShUNSPLRehrP_hhW_i-H4eQdy7aw1Px6POuiLbxNvswFG2IxTQqcnQ2927IRWiLbedD3dmUQ28_kcvWdsl9Pr9zsr6_Wy-W5er3z1-LH6tyI1DmUgADxVACR9GClE1VQ1WJ1mloeKMl5cA0Nli3grGNqFTtVM2cELrltdR8Tr6dtIcY_owuZdP7tHFdZwcXxmQAqYZKVxT_jyotUWqtjtabf9B9GOMw_eOFAs6Q0YmCE7WJIaXoWnOIvrfxyQA1xyDmFMRMQcwxiDmav57NY9275m3jtcAEsBOQptGwdfGv0-9anwGfdpP6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1695132720</pqid></control><display><type>article</type><title>Combining immunotherapy with radiation for the treatment of glioblastoma</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Chow, Kevin K. H. ; Hara, Wendy ; Lim, Michael ; Li, Gordon</creator><creatorcontrib>Chow, Kevin K. H. ; Hara, Wendy ; Lim, Michael ; Li, Gordon</creatorcontrib><description>Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in GBM have thus far shown modest benefit. Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence that radiation can enhance anti-tumor immunity. Here we review this evidence and discuss considerations for combined therapy.</description><identifier>ISSN: 0167-594X</identifier><identifier>EISSN: 1573-7373</identifier><identifier>DOI: 10.1007/s11060-015-1762-9</identifier><identifier>PMID: 25877468</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Brain Neoplasms - immunology ; Brain Neoplasms - therapy ; Combined Modality Therapy ; Editors' Invited Manuscript ; Glioblastoma - immunology ; Glioblastoma - therapy ; Humans ; Immunotherapy - methods ; Medicine ; Medicine & Public Health ; Neurology ; Oncology ; Radiotherapy - methods</subject><ispartof>Journal of neuro-oncology, 2015-07, Vol.123 (3), p.459-464</ispartof><rights>Springer Science+Business Media New York 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-412162751374f155d8b1884fe91d3d95031297d7bf422c486be6b2e449f3b593</citedby><cites>FETCH-LOGICAL-c475t-412162751374f155d8b1884fe91d3d95031297d7bf422c486be6b2e449f3b593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11060-015-1762-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11060-015-1762-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25877468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chow, Kevin K. H.</creatorcontrib><creatorcontrib>Hara, Wendy</creatorcontrib><creatorcontrib>Lim, Michael</creatorcontrib><creatorcontrib>Li, Gordon</creatorcontrib><title>Combining immunotherapy with radiation for the treatment of glioblastoma</title><title>Journal of neuro-oncology</title><addtitle>J Neurooncol</addtitle><addtitle>J Neurooncol</addtitle><description>Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in GBM have thus far shown modest benefit. Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence that radiation can enhance anti-tumor immunity. Here we review this evidence and discuss considerations for combined therapy.</description><subject>Brain Neoplasms - immunology</subject><subject>Brain Neoplasms - therapy</subject><subject>Combined Modality Therapy</subject><subject>Editors' Invited Manuscript</subject><subject>Glioblastoma - immunology</subject><subject>Glioblastoma - therapy</subject><subject>Humans</subject><subject>Immunotherapy - methods</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neurology</subject><subject>Oncology</subject><subject>Radiotherapy - methods</subject><issn>0167-594X</issn><issn>1573-7373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1rGzEQQEVJaBy3P6CXspBLL9to9DWrYzFJXTD04kNuQuvV2jK7K1fSEvLvs46dUAqhJx3mzRvEI-QL0O9AKd4mAKpoSUGWgIqV-gOZgUReIkd-QWYUFJZSi4crcp3SnlIqkMNHcsVkhShUNSPLRehrP_hhW_i-H4eQdy7aw1Px6POuiLbxNvswFG2IxTQqcnQ2927IRWiLbedD3dmUQ28_kcvWdsl9Pr9zsr6_Wy-W5er3z1-LH6tyI1DmUgADxVACR9GClE1VQ1WJ1mloeKMl5cA0Nli3grGNqFTtVM2cELrltdR8Tr6dtIcY_owuZdP7tHFdZwcXxmQAqYZKVxT_jyotUWqtjtabf9B9GOMw_eOFAs6Q0YmCE7WJIaXoWnOIvrfxyQA1xyDmFMRMQcwxiDmav57NY9275m3jtcAEsBOQptGwdfGv0-9anwGfdpP6</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Chow, Kevin K. H.</creator><creator>Hara, Wendy</creator><creator>Lim, Michael</creator><creator>Li, Gordon</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20150701</creationdate><title>Combining immunotherapy with radiation for the treatment of glioblastoma</title><author>Chow, Kevin K. H. ; Hara, Wendy ; Lim, Michael ; Li, Gordon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-412162751374f155d8b1884fe91d3d95031297d7bf422c486be6b2e449f3b593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Brain Neoplasms - immunology</topic><topic>Brain Neoplasms - therapy</topic><topic>Combined Modality Therapy</topic><topic>Editors' Invited Manuscript</topic><topic>Glioblastoma - immunology</topic><topic>Glioblastoma - therapy</topic><topic>Humans</topic><topic>Immunotherapy - methods</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neurology</topic><topic>Oncology</topic><topic>Radiotherapy - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chow, Kevin K. H.</creatorcontrib><creatorcontrib>Hara, Wendy</creatorcontrib><creatorcontrib>Lim, Michael</creatorcontrib><creatorcontrib>Li, Gordon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of neuro-oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chow, Kevin K. H.</au><au>Hara, Wendy</au><au>Lim, Michael</au><au>Li, Gordon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combining immunotherapy with radiation for the treatment of glioblastoma</atitle><jtitle>Journal of neuro-oncology</jtitle><stitle>J Neurooncol</stitle><addtitle>J Neurooncol</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>123</volume><issue>3</issue><spage>459</spage><epage>464</epage><pages>459-464</pages><issn>0167-594X</issn><eissn>1573-7373</eissn><abstract>Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in GBM have thus far shown modest benefit. Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence that radiation can enhance anti-tumor immunity. Here we review this evidence and discuss considerations for combined therapy.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>25877468</pmid><doi>10.1007/s11060-015-1762-9</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-594X |
ispartof | Journal of neuro-oncology, 2015-07, Vol.123 (3), p.459-464 |
issn | 0167-594X 1573-7373 |
language | eng |
recordid | cdi_proquest_miscellaneous_1709189807 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Brain Neoplasms - immunology Brain Neoplasms - therapy Combined Modality Therapy Editors' Invited Manuscript Glioblastoma - immunology Glioblastoma - therapy Humans Immunotherapy - methods Medicine Medicine & Public Health Neurology Oncology Radiotherapy - methods |
title | Combining immunotherapy with radiation for the treatment of glioblastoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A56%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combining%20immunotherapy%20with%20radiation%20for%20the%20treatment%20of%20glioblastoma&rft.jtitle=Journal%20of%20neuro-oncology&rft.au=Chow,%20Kevin%20K.%20H.&rft.date=2015-07-01&rft.volume=123&rft.issue=3&rft.spage=459&rft.epage=464&rft.pages=459-464&rft.issn=0167-594X&rft.eissn=1573-7373&rft_id=info:doi/10.1007/s11060-015-1762-9&rft_dat=%3Cproquest_cross%3E1695759969%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1695132720&rft_id=info:pmid/25877468&rfr_iscdi=true |